Molecules 2013, 18(3), 3060-3071; doi:10.3390/molecules18033060
Article

Repeated Oral Administration of Oleanolic Acid Produces Cholestatic Liver Injury in Mice

1,* email, 1email, 1email and 1,2,* email
Received: 27 December 2012; in revised form: 25 February 2013 / Accepted: 27 February 2013 / Published: 7 March 2013
(This article belongs to the Special Issue Triterpenes and Triterpenoids)
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract: Oleanolic acid (OA) is a triterpenoid and a fantastic molecule with many beneficial effects. However, high-doses and long-term use can produce adverse effects. This study aimed to characterize the hepatotoxic potential of OA. Mice were given OA at doses of 100–3,000 µmol/kg (45–1,350 mg/kg), po for 10 days, and the hepatotoxicity was determined by serum biochemistry, histopathology, and toxicity-related gene expression via real-time RT-PCR. Animal body weight loss was evident at OA doses of 1,000 µmol/kg and above. Serum alanine aminotransferase activities were increased in a dose-dependent manner, indicative of hepatotoxicity. Serum total bilirubin concentrations were increased, indicative of cholestasis. OA administration produced dose-dependent pathological lesions to the liver, including inflammation, hepatocellular apoptosis, necrosis, and feathery degeneration indicative of cholestasis. These lesions were evident at OA doses of 500 µmol/kg and above. Real-time RT-PCR revealed that OA produced dose-dependent increases in acute phase proteins (MT-1, Ho-1, Nrf2 and Nqo1), decreases in bile acid synthesis genes (Cyp7a1 and Cyp8b1), and decreases in liver bile acid transporters (Ntcp, Bsep, Oatp1a1, Oatp1b2, and Ostβ). Thus, the clinical use of OA and OA-type triterpenoids should balance the beneficial effects and toxicity potentials.
Keywords: oleanolic acid; oral administration; cholestasis; inflammation; bile acid synthesis; bile acid transporters
PDF Full-text Download PDF Full-Text [660 KB, uploaded 18 June 2014 20:03 CEST]

Export to BibTeX |
EndNote


MDPI and ACS Style

Lu, Y.-F.; Wan, X.-L.; Xu, Y.; Liu, J. Repeated Oral Administration of Oleanolic Acid Produces Cholestatic Liver Injury in Mice. Molecules 2013, 18, 3060-3071.

AMA Style

Lu Y-F, Wan X-L, Xu Y, Liu J. Repeated Oral Administration of Oleanolic Acid Produces Cholestatic Liver Injury in Mice. Molecules. 2013; 18(3):3060-3071.

Chicago/Turabian Style

Lu, Yuan-Fu; Wan, Xiao-Li; Xu, Yasha; Liu, Jie. 2013. "Repeated Oral Administration of Oleanolic Acid Produces Cholestatic Liver Injury in Mice." Molecules 18, no. 3: 3060-3071.

Molecules EISSN 1420-3049 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert